Kamada Ltd

KMDA

Company Profile

  • Business description

    Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

  • Contact

    2 Holzman Street
    P.O. Box 4081
    Science Park
    Rehovot7670402
    ISR

    T: +972 89406472

    E: [email protected]

    https://www.kamada.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    374

Stocks News & Analysis

stocks

Strong start to the year for cheap ASX share

Investors are ignoring a strong long-term outlook.
stocks

Are there signs of an AI bubble in Nvidia’s earnings?

Our view after third-quarter results.
stocks

Picking dividend shares in 2026? Here’s where to look

A new report from Morningstar shows opportunities for income investors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,686.308.30-0.10%
CAC 407,989.448.370.10%
DAX 4023,091.87186.98-0.80%
Dow JONES (US)46,245.41493.151.08%
FTSE 1009,531.013.360.04%
HKSE25,220.02615.55-2.38%
NASDAQ22,273.08195.030.88%
Nikkei 22548,625.881,198.06-2.40%
NZX 50 Index13,419.4020.00-0.15%
S&P 5006,602.9964.230.98%
S&P/ASX 2008,416.500.000.00%
SSE Composite Index3,834.8996.16-2.45%

Market Movers